My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Reasons for breast cancer heterogeneity.

    Bertucci F, Birnbaum D.

    J Biol. 2008;7(2):6. Review.PMID: 18304379 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Expression profiling technology: its contribution to our understanding of breast cancer.

    Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO.

    Histopathology. 2008 Jan;52(1):67-81. Review.PMID: 18171418 [PubMed - indexed for MEDLINE]Related articles

    3.

    MicroRNA involvement in the pathogenesis and management of breast cancer.

    Khoshnaw SM, Green AR, Powe DG, Ellis IO.

    J Clin Pathol. 2009 May;62(5):422-8. Review.PMID: 19398594 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cancer: micromanagement of metastasis.

    Steeg PS.

    Nature. 2007 Oct 11;449(7163):671-3. No abstract available. PMID: 17928850 [PubMed - indexed for MEDLINE]Related articles

    5.

    Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.

    Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Bénès V, Roché H, Dalenc F, Auboeuf D, Millevoi S, Vagner S.

    Cancer Res. 2009 Nov 1;69(21):8332-40. Epub 2009 Oct 13.PMID: 19826037 [PubMed - indexed for MEDLINE]Related articles

    6.

    Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

    Kakarala M, Wicha MS.

    J Clin Oncol. 2008 Jun 10;26(17):2813-20. Review.PMID: 18539959 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

    Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H.

    Cancer Res. 2008 Jul 1;68(13):5004-8.PMID: 18593897 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Heterogeneity in breast cancer and the problem of relevance of findings.

    Aubele M, Werner M.

    Anal Cell Pathol. 1999;19(2):53-8. Review.PMID: 10746434 [PubMed - indexed for MEDLINE]Related articles

    9.

    "New" molecular taxonomy in breast cancer.

    Hergueta-Redondo M, Palacios J, Cano A, Moreno-Bueno G.

    Clin Transl Oncol. 2008 Dec;10(12):777-85. Review.PMID: 19068448 [PubMed - indexed for MEDLINE]Related articles

    10.

    Involvement of microRNAs in breast cancer.

    Adams BD, Guttilla IK, White BA.

    Semin Reprod Med. 2008 Nov;26(6):522-36. Epub 2008 Oct 24. Review.PMID: 18951334 [PubMed - indexed for MEDLINE]Related articles

    11.

    ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation.

    Wang Y, Rathinam R, Walch A, Alahari SK.

    J Biol Chem. 2009 Aug 21;284(34):23094-106. Epub 2009 Jun 22.PMID: 19546220 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Different coexisting genotypes in the breast cancer cell line MDA-MB-468]

    Agelopoulos K, Schmidt H, Korsching E, Buerger H, Brandt B.

    Pathologe. 2008 Nov;29 Suppl 2:333-7. German. PMID: 18751981 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

    Calin GA, Croce CM.

    J Clin Invest. 2007 Aug;117(8):2059-66. Review.PMID: 17671640 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    MicroRNA-10b and breast cancer metastasis.

    Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM, Ragoussis J, Harris AL.

    Nature. 2008 Oct 23;455(7216):E8-9; author reply E9. No abstract available. PMID: 18948893 [PubMed - indexed for MEDLINE]Related articles

    15.

    Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program.

    Steeg PS.

    Clin Cancer Res. 2008 Jun 15;14(12):3643-5. No abstract available. PMID: 18559575 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.

    Shi M, Guo N.

    Cancer Treat Rev. 2009 Jun;35(4):328-34. Epub 2009 Jan 25. Review.PMID: 19171434 [PubMed - indexed for MEDLINE]Related articles

    17.

    CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

    Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

    Breast Cancer Res. 2009;11(1):R1. Epub 2009 Jan 5.PMID: 19123925 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.

    Yang S, Du J, Wang Z, Yan J, Yuan W, Zhang J, Zhu T.

    Int J Biochem Cell Biol. 2009 Apr;41(4):853-61. Epub 2008 Sep 2.PMID: 18805502 [PubMed - indexed for MEDLINE]Related articles

    19.

    A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.

    Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, McCue P, Pestell RG.

    J Cell Biol. 2008 Aug 11;182(3):509-17.PMID: 18695042 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

    Brunelli M, Manfrin E, Martignoni G, Miller K, Remo A, Reghellin D, Bersani S, Gobbo S, Eccher A, Chilosi M, Bonetti F.

    Am J Clin Pathol. 2009 May;131(5):678-82.PMID: 19369627 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk